ICICI Securities has retained its BUY call on Indo Count Industries, setting a revised 12-month target of Rs 418, versus a current market price of Rs 344. The brokerage’s thesis is straightforward: the company is emerging from a tariff-heavy disruption phase, and the next leg of growth could be powered by a rebound in core exports, a sharp scale-up in newer businesses, and margin normalization. Q4FY26 showed a mixed but constructive picture, with modest revenue growth, a stronger gross margin profile, and a meaningful rise in adjusted profit. The broader message is that near-term turbulence has not derailed the medium-term earnings expansion story.

The Q4 backdrop

Indo Count reported consolidated revenue of Rs 1,057.7 crore in Q4FY26, up 3.4% year on year, even as volumes fell 20% to 20.5 million metres. The decline in volumes was largely tariff-driven, but realizations improved because of a better product mix and a favorable currency environment. Gross margins expanded sharply by 588 basis points to 57.1%, reflecting softer input costs, although EBITDA margin still slipped 62 basis points to 8.2% because of operating pressure in the business mix. Adjusted PAT rose 60% year on year to Rs 33.8 crore, helped by higher other income and lower interest costs.

Why the stock looks interesting

The investment case rests on a recovery in the core bed-linen business and a rapid build-out of newer revenue streams. ICICI Securities expects the standalone core business to move toward Rs 4,000 crore in FY27, up from Rs 3,098 crore in FY26, aided by tariff relief, improving export competitiveness, stronger realizations, and better capacity utilization. The new business, which includes utility bedding and the US branded portfolio, is projected to nearly double to about Rs 1,500 crore in FY27 from Rs 792 crore in FY26. If those assumptions play out, the company’s revenue engine becomes both larger and more diversified.

Management’s operating reset

Management commentary suggests the worst of the tariff shock may be behind the company. The report notes that US demand remains steady, retailers have largely passed on higher prices, and customer ordering has normalized after tariff-related hesitation. Indo Count’s utility bedding business is also gaining scale after the North Carolina facility came on stream, lifting total pillow capacity to 31 million units and quilt capacity to 1.5 million units. ICICI Securities expects the utility bedding business to turn EBITDA positive from Q1FY27, which matters because it should reduce the drag from incubation costs.

Margin path and earnings profile

The brokerage sees consolidated EBITDA margins recovering to about 13% in FY27, with a longer-term path toward historical levels above 15%. That is a significant improvement from the 9.7% margin recorded in FY26, when tariffs, new-business ramp-up costs, and lower operating leverage squeezed profitability. The report also expects the core business margin to normalize near 15% and branded businesses to produce superior margins over time. ICICI Securities slightly trimmed FY27 earnings estimates, but largely left FY28 forecasts intact, signaling confidence that the medium-term story remains on track.

Target, valuation, and levels

ICICI Securities values Indo Count at 16 times FY28 estimated EPS of Rs 26, which yields a target price of Rs 418. At the current price of Rs 344, that implies an upside of about 21%, comfortably above the brokerage’s Buy threshold. For investors, the immediate reference levels from the report are clear: near-term support is around the current market zone of Rs 340 to Rs 344, while the first meaningful upside objective sits near Rs 418. Beyond that, the stock’s re-rating will likely depend on execution in FY27, especially the pace of volume recovery and margin restoration.

What could go wrong

The report does flag risks that investors should not ignore. A renewed 50% US tariff regime would pressure margins again and could delay the expected rebound in core volumes. The company is also exposed to demand softness in its key markets and to foreign-currency volatility. In addition, raw material inflation in cotton, polyester, chemicals, energy, and packaging could compress margins if the company is unable to pass through higher costs quickly enough.

Dalaal Street readout

For market participants, this is not a flashy turnaround story; it is a measured recovery thesis with operating leverage potential. Indo Count is being positioned as a beneficiary of tariff normalization, portfolio diversification, and improving utilization across both legacy and new businesses. The stock still trades on the credibility of execution, but the brokerage’s numbers suggest that earnings can rise sharply if FY27 plays out as guided. In that sense, the report reads like a classic earnings reset: short-term disruption, medium-term recovery, and a valuation that remains anchored to improving fundamentals.